The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Linking β-Catenin to Androgen-signaling Pathway
Open accessAbstract
The androgen-signaling pathway is important for the growth and progression of prostate cancer cells. The growth-promoting effects of androgen on prostate cells are mediated mostly through the androgen receptor (AR). There is increasing evidence that transcription activation by AR is mediated through interaction with other cofactors. beta-Catenin plays a critical role in embryonic development and tumorigenesis through its effects on E-cadherin-mediated cell adhesion and Wnt-dependent signal transduction. Here, we demonstrate that a specific protein-protein interaction occurs between beta-catenin and AR. Unlike the steroid hormone receptor coactivator 1 (SRC1), beta-catenin showed a strong interaction with AR but not with other steroid hormone receptors such as estrogen receptor alpha, progesterone receptor beta, and glucocorticoid receptor. The ligand binding domain of AR and the NH(2) terminus combined with the first six armadillo repeats of beta-catenin were shown to be necessary for the interaction. Through this specific interaction, beta-catenin augments the ligand-dependent activity of AR in prostate cancer cells. Moreover, expression of E-cadherin in E-cadherin-negative prostate cancer cells results in redistribution of the cytoplasmic beta-catenin to the cell membrane and reduction of AR-mediated transcription. These data suggest that loss of E-cadherin can elevate the cellular levels of beta-catenin in prostate cancer cells, which may directly contribute to invasiveness and a more malignant tumor phenotype by augmenting AR activity during prostate cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While FKBP52 is known to functionally interact with AR, GR and PR [6–8], β-catenin only interacts strongly with AR, but not GR and PR [20].”
From The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling (2015) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Landis, S., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P. M., Halladay, J. T., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,638
β‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,398
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Flagged first, then by citations
Research works printed but not linked: 12
- Jenster, 1999, Semin. Oncol., 26, 407
- Gayther, 1998, Cancer Res., 58, 4086
- Richmond, 1997, Cancer Res., 57, 3189
- Sasaki, 2000, Cancer Res., 60, 7057
- Truica, 2000, Cancer Res., 60, 4709
- Shibata, 1997, Recent Prog. Horm. Res., 52, 141
- Pang, 1997, Cancer Res., 57, 495
- Birchmeier, 1995, Cancer Surv., 24, 129
- Umbas, 1992, Cancer Res., 52, 5104
- Graff, 1995, Cancer Res., 55, 5195
- Voeller, 1998, Cancer Res., 58, 2520
- van de Wetering, 2001, Cancer Res., 61, 278
Cited by
Sorted by citations
Items 201–300 of 342
Brauer, P. M., Zheng, Y., Evans, M. D., Dominguez‐Brauer, C., Peehl, D. M., & Tyner, A. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014789 · Cited by 28
Yue, P., Lee, J., Zhu, C., & Sun, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079327 · Cited by 27
Self-citationGarikapaty, V. P. S., Ashok, B. T., Tadi, K., Mittelman, A., & Tiwari, R. K. (2005) · The Prostate · doi:10.1002/pros.20350 · Cited by 27
Du, C., Zhang, C., Li, Z., Biswas, M. H. U., & Balaji, K. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033830 · Cited by 26
Azmahani, A., Nakamura, Y., Ozawa, Y., McNamara, K. M., Fujimura, T., Haga, T., Hashimoto, A., Aiba, S., & Sasano, H. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.07.007 · Cited by 25
He, Y., Mi, J., Olson, A. W., Aldahl, J., Hooker, E., Yu, E., Le, V. L., Lee, D., Kim, W. K., Robins, D. M., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1214-7 · Cited by 25
Self-citationQuan, G., Xu, J., Wang, J., Liu, X., Xu, J., & Jiang, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05679-2 · Cited by 25
Cho‐Vega, J. H., Tsavachidis, S., Do, K.-A., Nakagawa, J., Medeiros, L. J., & McDonnell, T. J. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0684 · Cited by 25
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target
Yeoh, C. C., Dabab, N., Rigby, E., Chhikara, R., Akaev, I., Gomez, R. S., Fonseca, F. P., Brennan, P. A., & Rahimi, S. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12741 · Cited by 26
Involvement of three glutamine tracts in human androgen receptor transactivation
Harada, N., Mitani, T., Higashimura, Y., Yamaji, R., Okamoto, K., Nakano, Y., & Inui, H. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.10.003 · Cited by 24
Li, J., Xing, J., Lu, F., Chang, W., Liang, N., Li, J., Wang, Y., Li, X., Zhao, X., Hou, R., et al. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3480 · Cited by 24
Self-citationExpression of β-Catenin in Prostatic Adenocarcinomas
Bismar, T. A., Humphrey, P. A., Grignon, D. J., & Wang, H. L. (2004) · American Journal of Clinical Pathology · doi:10.1309/447049gv52h7d258 · Cited by 24
Molecular markers in the diagnosis of prostate cancer
van der Poel, H. G. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.003 · Cited by 23
Cristóbal, I., Rojo, F., Madoz‐Gúrpide, J., & García‐Foncillas, J. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00130-16 · Cited by 23
Multiple oncogenic roles of nuclear β-catenin
Kumar, R., & Bashyam, M. D. (2017) · Journal of Biosciences · doi:10.1007/s12038-017-9710-9 · Cited by 25
Mumford, P. W., Romero, M. A., Mao, X., Mobley, C. B., Kephart, W. C., Haun, C. T., Roberson, P. A., Young, K. C., Martin, J. S., Yarrow, J. F., et al. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00768.2017 · Cited by 23
Cardaci, T. D., Machek, S. B., Wilburn, D. T., Heileson, J. L., & Willoughby, D. S. (2020) · Nutrients · doi:10.3390/nu12123829 · Cited by 26
Kim, W. K., Olson, A. W., Mi, J., Wang, J., Lee, D., Le, V. L., Hiroto, A., Aldahl, J., Nenninger, C. H., Buckley, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32119-0 · Cited by 23
Self-citationZhang, L.-F., Qin, C., Wei, Y., Wang, Y., Chang, J., Mi, Y.-Y., Ma, L., Jiang, J., Feng, N.-H., Wang, Z., et al. (2011) · Systems Biology in Reproductive Medicine · doi:10.3109/19396368.2011.577509 · Cited by 23
Gender specific LRP5 influences on trabecular bone structure and strength.
Dubrow, S., Hruby, P. M., & Akhter, M. P. (2007) · PubMed · Cited by 23
Song, L., & Gelmann, E. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800325200 · Cited by 22
Does prostate cancer co-opt the developmental program?
Marker, P. C. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00297.x · Cited by 22
Polyphenic trait promotes liver cancer in a model of epigenetic instability in mice
Cassano, M., Offner, S., Planet, E., Piersigilli, A., Jang, S. M., Henry, H., Geuking, M. B., Mooser, C., McCoy, K. D., Macpherson, A. J., et al. (2017) · Hepatology · doi:10.1002/hep.29182 · Cited by 22
Stromal cell interplay in prostate development, physiology, and pathological conditions
Sanches, B. D. A., Maldarine, J. S., Vilamaior, P. S. L., Felisbino, S. L., Carvalho, H. F., & Taboga, S. R. (2021) · The Prostate · doi:10.1002/pros.24196 · Cited by 21
Górowska-Wójtowicz, E., Zarzycka, M., Chojnacka, K., Bilińska, B., & Hejmej, A. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00172.x · Cited by 21
Axin2 expression identifies progenitor cells in the murine prostate
Ontiveros, C. S., Salm, S. N., & Wilson, E. L. (2008) · The Prostate · doi:10.1002/pros.20770 · Cited by 21
Hikichi, Y., Yamaoka, M., Kusaka, M., & Hara, T. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.052 · Cited by 20
He, Y., Hooker, E., Yu, E., Cunha, G. R., Liao, L., Xu, J., Earl, A., Wu, H., Gonzalgo, M. L., & Sun, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0583-7 · Cited by 20
Self-citationβ-Catenin Stabilization in Gonadotropes Impairs FSH Synthesis in Male Mice In Vivo
Boerboom, D., Kumar, V., Boyer, A., Wang, Y., Lambrot, R., Zhou, X., Rico, C., Boehm, U., Paquet, M., Céleste, C., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1296 · Cited by 19
LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis
Yu, E., Hooker, E., Johnson, D. T., Kwak, M. K., Zou, K., Luong, R. H., He, Y., & Sun, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174357 · Cited by 20
Self-citationPrognostic markers inprostate cancer
Ross, J. S., Sheehan, C. E., Fisher, H. A. �., Kaufman, R., Dolen, E. M., & Kallakury, B. (2002) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2.2.129 · Cited by 19
Wang, K., Li, N., Yeung, C., Cooper, T., Liu, X., Liu, J., Wang, W., Li, Y., Shi, H., & Liu, F. (2015) · Asian Journal of Andrology · doi:10.4103/1008-682x.157396 · Cited by 18
Regional Expression of Androgen Receptor Coregulators and Androgen Action in the Mouse Epididymis
Sipilä, P., Krutskikh, A., Pujianto, D. A., POUTANEN, M. H., & Huhtaniemi, I. T. (2011) · Journal of Andrology · doi:10.2164/jandrol.110.012914 · Cited by 18
The β-Catenin Binding Protein ICAT Modulates Androgen Receptor Activity
Zhuo, M., Zhu, C., Sun, J., Weis, W. I., & Sun, Z. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1023 · Cited by 17
Self-citationZhang, K., Firus, J., Prieur, B., Jia, W. W.-G., & Rennie, P. S. (2011) · Cancers · doi:10.3390/cancers3021498 · Cited by 18
He, Y., Hooker, E., Yu, E., Wu, H., Cunha, G. R., & Sun, Z. (2018) · Stem Cells · doi:10.1002/stem.2806 · Cited by 17
Self-citationLi, F., Song, C. M., Zhang, Y., & Wu, D. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2021001 · Cited by 16
Lazari, P., Poulias, H., Gakiopoulou, H., Thomopoulou, G.-H., Barbatis, C., & Lazaris, A. C. (2012) · Urologia Internationalis · doi:10.1159/000345057 · Cited by 16
Lombard, A. P., Liu, C., Armstrong, C. M., D'Abronzo, L. S., Lou, W., Evans, C. P., & Gao, A. C. (2019) · PubMed Central · Cited by 16
Zou, Y., Huang, Y., Hong, B., Xiang, X., Zhou, B., & Wei, S. (2020) · PubMed · doi:10.14670/hh-18-156 · Cited by 16
Role of bromodomain and extraterminal (BET) proteins in prostate cancer
Mandl, A., Markowski, M. C., Carducci, M. A., & Antonarakis, E. S. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2186851 · Cited by 16
Jeet, V., Ow, K. T., Doherty, E., Curley, B., Russell, P. J., & Khatri, A. (2008) · The Prostate · doi:10.1002/pros.20714 · Cited by 17
Interactions between androgen and IGF1 axes in prostate tumorigenesis
Adzavon, Y. M., Čulig, Z., & Sun, Z. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00942-3 · Cited by 17
Self-citationAndrogen receptor functions in prostate cancer development and progression
Balk, S. P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.126396 · Cited by 15
Brown, N. E., Paluch, A. M., Nashu, M. A., Komurov, K., & Waltz, S. E. (2018) · Neoplasia · doi:10.1016/j.neo.2018.07.003 · Cited by 15
Pelosi, G., Scarpa, A., Veronesi, G., Spaggiari, L., Curto, B. D., Moore, P. S., Maisonneuve, P., Sonzogni, A., Masullo, M., & Viale, G. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-0044-x · Cited by 15
Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer
Manzar, N., Ganguly, P., Khan, U. K., & Ateeq, B. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.004 · Cited by 14
Martinez, H. D., Hsiao, J. J., Jasavala, R. J., Hinkson, I. V., Eng, J. K., & Wright, M. E. (2011) · Genes & Cancer · doi:10.1177/1947601912436422 · Cited by 14
Kollara, A., Shathasivam, P., Park, S., Ringuette, M. J., & Brown, T. J. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105498 · Cited by 14
The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling
Storer Samaniego, C., Suh, J. H., Chattopadhyay, A., Olivares, K., Guy, N., Sivils, J. C., Dey, P., Yumoto, F., Fletterick, R. J., Strom, A. M., et al. (2015) · PLOS One · doi:10.1371/journal.pone.0134015 · Cited by 13
Aldahl, J., Mi, J., Pineda, A., Kim, W. K., Olson, A. W., Hooker, E., He, Y., Yu, E., Le, V. L., Lee, D.-H., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011137 · Cited by 13
Self-citationFang, F., Qin, Y., Feng, H., Li, Q., Zhang, W. J., Zhao, C., Chen, S., Zhao, L., Wang, L., & Cai, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.4684 · Cited by 13
Martinez, S. R., Elix, C. C., Ochoa, P. T., Sanchez-Hernández, E. S., Alkashgari, H. R., Ortiz-Hernández, G. L., Zhang, L., & Casiano, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087130 · Cited by 12
Targeting bone physiology for the treatment of metastatic prostate cancer.
Autio, K. A., & Morris, M. J. (2013) · PubMed · Cited by 12
Intrinsic material properties of cortical bone
Franco, G. E. L., Blank, R. D., & Akhter, M. P. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0194-z · Cited by 12
Huang, C., Li, F. X., Pan, S., Xu, C., Dai, J. Q., & Zhao, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7488 · Cited by 12
Jiang, D., Xiao, C., Xian, T., Wang, L., Mao, Y., Zhang, J., & Pang, J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157295 · Cited by 12
Ablin, R. J., & Mason, M. D. (2007) · Cancer metastasis · doi:10.1007/978-1-4020-5847-9 · Cited by 13
The androgen receptor: molecular biology
Klocker, H., Gromoll, J., & Cato, A. C. B. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545221.003 · Cited by 12
Delineating the role of nuclear receptors in colorectal cancer, a focused review
Manickasamy, M. K., Jayaprakash, S., Girisa, S., Kumar, A., Lam, H. Y., Okina, E., Eng, H., Alqahtani, M. S., Abbas, M. A. E., Sethi, G., et al. (2024) · Discover Oncology · doi:10.1007/s12672-023-00808-x · Cited by 11
Micronutrients and Androgenetic Alopecia: A Systematic Review
Wang, R., Lin, J., Liu, Q., Wu, W., Wu, J., & Liu, X. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400652 · Cited by 14
Mechanisms of androgenic action in adipose tissue
Veilleux, A., & Blouin, K. (2009) · Clinical Lipidology · doi:10.2217/clp.09.16 · Cited by 10
Minireview: Steroid/Nuclear Receptor-Regulated Dynamics of Occluding and Anchoring Junctions
Firestone, G. L., & Kapadia, B. J. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1037 · Cited by 11
Chow, A., Amemiya, Y., Sugar, L., Nam, R. K., & Seth, A. K. (2012) · PubMed · Cited by 11
Prognostic and Therapeutic Significance of Androgen Receptor in Patients with Gastric Cancer
Fard, S. S., Yazdanbod, M., Sotoudeh, M., Bashash, D., Mahmoodzadeh, H., Saliminejad, K., Mousavi, S. A., Ghaffari, S. H., & Alimoghaddam, K. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s265364 · Cited by 10
Prostate carcinoma and stem cells
Aparicio, L. M. A., Espinosa, J., Campelo, R. G., Veiga, F. G., Díaz‐Prado, S., & Gallego, G. A. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0015-6 · Cited by 10
Cullen, D. A., Killick, R., Leigh, P. N., & Gallo, J. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.074 · Cited by 10
Estrogen Receptors Critically Regulate Bones’ Adaptive Responses to Loading
Lanyon, L. E., Armstrong, V. J., Saxon, L., Sunters, A., Sugiyama, T., Zaman, G., & Price, J. S. (2007) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-008-9011-9 · Cited by 10
EXPRESSION OFβ-CATENIN IN HUMAN TESTES WITH SPERMATOGENIC DEFECTS
Lee, J. H., Choi, K. W., Lee, S. J., & Gye, M. C. (2005) · Archives of Andrology · doi:10.1080/014850190923387 · Cited by 9
Molecular signals governing cremaster muscle development: Clues for cryptorchidism
Szarek, M., Li, R., Vikraman, J., Southwell, B. R., & Hutson, J. M. (2013) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2013.11.049 · Cited by 9
Mitosis orientation in prostate epithelial cells changed by endocrine effect
Liu, X., Li, D., Zhang, X., Wu, J., & Sun, Z. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00728.x · Cited by 8
Self-citationIdentification of neuron selective androgen receptor inhibitors
Otto‐Duessel, M., Tew, B. Y., Vonderfecht, S. L., Moore, R. E., & Jones, J. O. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i2.138 · Cited by 9
Hsu, H.-T., Liu, P.-C., Ku, S., Jung, K.-C., Hong, Y., Kao, C. H., & Wang, C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.193 · Cited by 8
Moens, L., Soetaert, A., van der Ven, K., Del‐Favero, J., & Coen, W. M. D. (2006) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2006.10.004 · Cited by 8
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer
Broderick, A. J., Pan, E., Li, J., Chu, A., Hwang, C., Barata, P. C., Cackowski, F. C., Labriola, M., Ghose, A., Bilen, M. A., et al. (2024) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-024-00869-1 · Cited by 7
Moon, H. H., Clines, K. L., Cooks, M. A., Cialek, C. A., Esvelt, M. A., & Clines, G. A. (2019) · Endocrinology · doi:10.1210/en.2019-00261 · Cited by 7
Horton, C., Liu, Y., Wang, J., Green, J., Tsyporin, J., Chen, B., & Wang, Z. A. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.04.003 · Cited by 11
Androgens and Prostate Cancer Bone Metastases: Effects on Both the Seed and the Soil
Yang, W., & Levine, A. C. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.05.001 · Cited by 8
Androgen Receptor Function in Prostate Cancer Progression
Klocker, H., Eder, I. E., Comuzzi, B., Bartsch, G. H., & Čulig, Z. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-224-3_6 · Cited by 7
Park, E., Kim, E. K., Kim, M. K., Ha, J. M., Kim, Y. W., Jin, S. Y., Shin, H. K., Ha, H. K., Lee, J. Z., & Bae, S. S. (2015) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2015.19.3.235 · Cited by 7
Zhang, P., Schaefer-Klein, J. L., Cheville, J. C., Vasmatzis, G., & Kovtun, I. V. (2018) · Oncotarget · doi:10.18632/oncotarget.25319 · Cited by 7
Noncanonical Wnt as a prognostic marker in prostate cancer: “you can’t always get what you Wnt”
Fisher, R., Pleskow, H. M., Bedingfield, K., & Miyamoto, D. T. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1702522 · Cited by 7
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer
Choi, S. H., Pan, E., Elliott, A., Beltran, H., Panian, J. A., Jamieson, C. A. M., Bagrodia, A., Rose, B. S., Herchenhorn, D., Heath, E. I., et al. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0395 · Cited by 6
Kim, D. H., Im, E., Lee, D., Lee, H., Sim, D. Y., Park, J. E., Ahn, C., Koo, J. I., Pak, J., & Kim, S. (2022) · Phytotherapy Research · doi:10.1002/ptr.7494 · Cited by 7
Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
Nesterova, A. P., & Yuryev, A. (2017) · InTech eBooks · doi:10.5772/67845 · Cited by 6
Suresh, P. S., & Medhamurthy, R. (2012) · Growth Factors · doi:10.3109/08977194.2012.678844 · Cited by 6
Takemaru, K. (2006) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000506.01 · Cited by 6
Yu, T., Peng, D.-D., Liang, X., Nie, W., Tan, H.-C., Chen, S.-Y., Shi, H.-S., Wei, Y.-Q., & Wei, X.-W. (2025) · Drug resistance updates · doi:10.1016/j.drup.2025.101331 · Cited by 5
Nakata, D., Koyama, R., Nakayama, K., Kitazawa, S., Watanabe, T., & Hara, T. (2017) · The Prostate · doi:10.1002/pros.23351 · Cited by 5
Molecular Genetic Etiology of Prostate Cancer
Pethe, V. V., & Bapat, B. V. (2008) · The Open Genomics Journal · doi:10.2174/1875693x00801010013 · Cited by 5
Ali, A. K., Abu-Raghif, A. R., & Ridha‐Salman, H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05044-y · Cited by 4
Harati, S., Cooper, L., Moran, J. D., Giuste, F., Du, Y., Ivanov, A. A., Johns, M. A., Khuri, F. R., Fu, H., & Moreno, C. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170339 · Cited by 4
Prigol, A. N., Silva, A. H., Rode, M. P., Stulzer, H. K., Cruz, L. A., Carson, D. D., Farach‐Carson, M. C., Pittella, F., & Creczynski‐Pasa, T. B. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125984 · Cited by 3
Huang, Y., & He, T. (2025) · Discover Oncology · doi:10.1007/s12672-025-04104-8 · Cited by 3
Molecular Aspects of Sebaceous Differentiation
Zouboulis, C. C., Nikolakis, G. D., & Dessinioti, C. (2014) · Springer eBooks · doi:10.1007/978-3-540-69375-8_3 · Cited by 3
Transición epitelial-mesenquimal en la progresión del adenocarcinoma prostático
de Cartagena, U., Inés Benedetti, P., Reyes, N., & de Cartagena, U. (2015) · IATREIA · doi:10.17533/udea.iatreia.v28n4a07 · Cited by 3
Maund, S. L., & Cramer, S. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00323-5 · Cited by 3
Poxleitner, P. J., Shoumariyeh, K., Steybe, D., Hupfer, V., Voss, P. J., Rawluk, J. K., Ermer, M. A., Miething, C., Schmelzeisen, R., & Duyster, J. (2020) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2019.12.012 · Cited by 3
Androgen Receptor Biology in Prostate Cancer
Gelmann, E. P. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_5 · Cited by 2
Hurt, E. M., Klarmann, G. J., Kawasaki, B. T., Sharifi, N., & Farrar, W. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-89611-3_6 · Cited by 2
Metadata
- Authors
- Yang, F., Li, X., Sharma, M., Sasaki, C. Y., Longo, D. L., Lim, B., & Sun, Z.
- Affiliations
- Stanford Medicine (US)
- Beth Israel Deaconess Medical Center (US)
- National Institutes of Health (US)
- Corresponding author
- Sun, Zijie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 13
- Pages
- 11336-11344
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022810442
- Cited by
- 342
- References
- 54
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 4 · 2020: 10 · 2019: 14 · 2018: 10 · 2017: 19 · 2016: 7 · 2015: 17 · 2014: 12 · 2013: 19 · 2012: 10
- FWCI
- 20.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01dk054417-01)
- National Cancer Institute (CA-70297, R01CA087767, R29CA070297, R01CA070297)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK061002, DK54417, R56DK061002, R01DK047636, DK47636)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- β-catenin, androgen receptor, androgen signaling, prostate cancer, protein-protein interaction, E-cadherin, Wnt signaling, armadillo repeats, transcriptional coactivation, steroid hormone receptors, tumor progression, cell adhesion
- MeSH terms
- Androgens, Cytoskeletal Proteins, Humans, Ligands, Male, Prostatic Neoplasms, Receptors, Androgen, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Two-Hybrid System Techniques, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review